Drug intelligence / Profile preview

TLC Vita OB

Development stage: Unknown
Lead developer: Remed Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

TLC Vita OB is a nutritional supplement and iron preparation developed by Remed Pharmaceuticals, Inc. for the prevention and treatment of iron-vitamin and dietary deficiency anemias, particularly during pregnancy. Formulated as an oral capsule, it contains a combination of iron and essential vitamins designed to support erythropoiesis (red blood cell production) and correct iron-deficiency anemia. The product is manufactured by Lloyd Laboratories, Inc. and is currently marketed in the Philippines as an obstetric (OB) supplement to support maternal health.

Brand names: TLC Vita OB
Other names: TLC VITA OB

Beyond the preview

Go deeper on TLC Vita OB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TLC Vita OB.

Explore the full profile